Skip to main content
Equibles

Wouter Joustra

Board Member

Vor Biopharma Inc. (VOR)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Wouter Joustra

Wouter Joustra is recorded as Board Member at Vor Biopharma Inc. (VOR). Vor Biopharma Inc. reported in an 8-K filed December 18, 2025 that Wouter Joustra was appointed Class III director. Vor Biopharma Inc. reported in an 8-K filed December 18, 2025 that Wouter Joustra was appointed independent Class III director, effective December 18, 2025.

“the Company agrees to appoint one individual designated by Forbion to the Company’s Board of Directors as a Class III director, who shall initially be Wouter Joustra, subject to approval by the Company’s Board of Directors upon the recommendation of the Nominating & Corporate Governance Committee of the Board of Directors (the “N&CG Committee”), which approval shall not be unreasonably withheld (the “Forbion Appointed Director”), effective as soon as practicable following the Closing Date by taking all necessary action by the Company or its Board of Directors to effect such appointment.”
Vor Biopharma Inc. Form 8-K, filed December 18, 2025 · Read the filing
“On December 18, 2025, the Board appointed Wouter Joustra to serve on the Board as an independent Class III director until the Company's 2027 annual meeting of stockholders and until his successor is duly elected and qualified or his earlier resignation or removal.”
Vor Biopharma Inc. Form 8-K, filed December 18, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Vor Biopharma Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.